Status:
COMPLETED
A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)
Lead Sponsor:
Takeda
Conditions:
Relapse and/or Refractory Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
The main aim of this study is to see how people with MM respond to previous or current treatment. Participants will be treated according to their clinic's standard practice. Each participant will fil...
Detailed Description
This is a non- interventional, retrospective epidemiological study of participants with MM. The study will characterize MM participants with symptomatic relapse and/or refractory (R/R) disease. The s...
Eligibility Criteria
Inclusion
- At least one previous treatment line.
- Symptomatic R/R disease in the previous 6 months to study enrolment.
- Receiving treatment with an accurate and thorough data fulfilled in their participant's medical records available at the study site.
- On regular follow-up for relapse and/or refractory disease during the recruitment period at the study site.
- Capable of understanding and completing both QoL questionnaires (EORTC QLQ-C30 and EORTC QLQ-MY20).
Exclusion
- Diagnosed with MM more than 5 years previous to inclusion in this study.
- Diagnosed with any malignancy other than MM or its complications within the past 5 years.
- Currently participating in a clinical trial for his MM or having participated in a clinical trial within 5 years before inclusion.
- Diagnosed with any hematological disease other than MM or its complications.
Key Trial Info
Start Date :
July 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04135963
Start Date
July 31 2020
End Date
September 30 2022
Last Update
October 23 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Clinico Academico Hospital de Braga
Braga, Portugal, 4710-243
2
Centro Hospitalar e Universitario de Coimbra. EPE
Coimbra, Portugal, 3004-561
3
Instituto Portugues de Oncologia de Lisboa Francisco Gentil (IPO)
Lisbon, Portugal, 1099-023
4
Centro Hospitalar Lisboa Norte EPE - Hospital de Santa Maria
Lisbon, Portugal, 1649-028